ACLX - Arcellx, Inc.
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $-1.01
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$110.00
DETAILS
HIGH:
$120.00
LOW:
$82.00
MEDIAN:
$115.00
CONSENSUS:
$110.00
DOWNSIDE:
3.30%
Market Cap:
6.58B
Volume:
19,199,953
Avg Volume:
1,083,556
52 Week Range:
47.86-113.9
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.36
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
163
IPO Date:
2022-02-04
EPS (TTM):
-2.00
P/E Ratio:
-38.27
Revenue (TTM):
107.94M
Total Assets:
711.33M
Total Debt:
54.08M
Cash & Equiv:
105.68M
Rev Growth (5Y):
-2.2%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-17.8%
Debt/Equity:
0.12
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-05 | $-0.99 | $-0.96 | -3.1% | $4.9M | $12.6M | -60.9% |
| 2025-08-07 | $-0.94 | $-1.03 | +8.7% | $7.6M | $13.7M | -44.9% |
| 2025-05-08 | $-1.13 | $-0.84 | -34.5% | $8.1M | $12.9M | -36.8% |
| 2025-02-27 | $-0.87 | $-0.63 | -38.1% | $15.3M | $25.7M | -40.6% |
| 2024-11-07 | $-0.48 | $-0.54 | +11.1% | $26.0M | $38.7M | -32.8% |
| 2024-08-08 | $-0.51 | $-0.54 | +5.6% | $27.4M | $22.0M | +24.3% |
| 2024-05-09 | $-0.14 | $-0.51 | +72.5% | $39.3M | $20.7M | +90.0% |
| 2024-02-28 | $0.42 | $-0.61 | +168.9% | $63.1M | $20.1M | +214.7% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 107.94M | 110.32M | 0 | 0 | 0 | 0 | 0 |
| Net Income | (107.35M) | (70.69M) | (188.68M) | (64.97M) | (32.09M) | (17.97M) | (8.31M) |
| EPS | -2.00 | -1.47 | -4.28 | -1.94 | -1.47 | -0.52 | -50.17 |
| Total Assets | 711.33M | 825.13M | 313.82M | 128.78M | 57.69M | 43.59M | 15.81M |
| Total Debt | 54.08M | 97.62M | 88.13M | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 105.68M | 394.58M | 64.18M | 30.83M | 46.60M | 34.58M | 14.53M |
| Operating Cash Flow | (83.47M) | 207.57M | (99.30M) | (54.24M) | (28.66M) | (18.77M) | (6.86M) |
| Free Cash Flow | (96.90M) | 186.15M | (101.58M) | (60.02M) | (29.55M) | (22.60M) | (7.34M) |
| FCF per Share | -1.81 | 3.87 | -2.30 | -1.79 | -1.36 | -0.65 | -44.33 |
| Book Value | 454.79M | 485.38M | 204.95M | (121.52M) | 50.54M | (32.74M) | 13.96M |
| Cash & ST Investments | 587.38M | 702.02M | 254.84M | 104.62M | 46.60M | 34.58M | 14.53M |
| ROC Equity | -0.24 | -0.15 | -0.92 | N/A | -0.64 | N/A | -0.60 |